nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC15A2—melanoma	0.765	1	CbGaD
Cefadroxil—SLC22A5—Dactinomycin—melanoma	0.14	1	CbGbCtD
Cefadroxil—Infertility—Carmustine—melanoma	0.00439	0.05	CcSEcCtD
Cefadroxil—Infertility—Temozolomide—melanoma	0.00424	0.0483	CcSEcCtD
Cefadroxil—Nephropathy toxic—Bleomycin—melanoma	0.00228	0.026	CcSEcCtD
Cefadroxil—Nephropathy toxic—Carmustine—melanoma	0.00199	0.0227	CcSEcCtD
Cefadroxil—Digestion impaired—Temozolomide—melanoma	0.00165	0.0189	CcSEcCtD
Cefadroxil—Cholestasis—Temozolomide—melanoma	0.00146	0.0166	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00141	0.0161	CcSEcCtD
Cefadroxil—Eosinophilia—Vemurafenib—melanoma	0.00134	0.0153	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0012	0.0137	CcSEcCtD
Cefadroxil—Aplastic anaemia—Dactinomycin—melanoma	0.00115	0.0131	CcSEcCtD
Cefadroxil—Vaginal inflammation—Temozolomide—melanoma	0.00111	0.0126	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Temozolomide—melanoma	0.00111	0.0126	CcSEcCtD
Cefadroxil—Vaginal infection—Temozolomide—melanoma	0.00104	0.0119	CcSEcCtD
Cefadroxil—Aplastic anaemia—Temozolomide—melanoma	0.00104	0.0118	CcSEcCtD
Cefadroxil—Erythema multiforme—Vemurafenib—melanoma	0.00103	0.0117	CcSEcCtD
Cefadroxil—Hepatic failure—Dactinomycin—melanoma	0.000988	0.0113	CcSEcCtD
Cefadroxil—Swelling—Carmustine—melanoma	0.000942	0.0107	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000923	0.0105	CcSEcCtD
Cefadroxil—Hepatic failure—Temozolomide—melanoma	0.000894	0.0102	CcSEcCtD
Cefadroxil—Arthralgia—Vemurafenib—melanoma	0.000806	0.00918	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000799	0.00911	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000799	0.00911	CcSEcCtD
Cefadroxil—Pancytopenia—Bleomycin—melanoma	0.000781	0.0089	CcSEcCtD
Cefadroxil—Cefuroxime—SLC15A2—melanoma	0.000779	0.116	CrCbGaD
Cefadroxil—Blood bilirubin increased—Docetaxel—melanoma	0.000778	0.00886	CcSEcCtD
Cefadroxil—Anaphylactic shock—Vemurafenib—melanoma	0.000772	0.0088	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Docetaxel—melanoma	0.000736	0.00838	CcSEcCtD
Cefadroxil—Pancytopenia—Dactinomycin—melanoma	0.000729	0.0083	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000723	0.00824	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000723	0.00824	CcSEcCtD
Cefadroxil—Neutropenia—Dactinomycin—melanoma	0.000718	0.00818	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Temozolomide—melanoma	0.000708	0.00807	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000704	0.00802	CcSEcCtD
Cefadroxil—Pancytopenia—Carmustine—melanoma	0.000682	0.00777	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000678	0.00773	CcSEcCtD
Cefadroxil—Cefixime—SLC15A2—melanoma	0.000673	0.101	CrCbGaD
Cefadroxil—Neutropenia—Carmustine—melanoma	0.000672	0.00765	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Vemurafenib—melanoma	0.000667	0.0076	CcSEcCtD
Cefadroxil—Haemoglobin—Bleomycin—melanoma	0.000662	0.00754	CcSEcCtD
Cefadroxil—Pancytopenia—Temozolomide—melanoma	0.000659	0.00751	CcSEcCtD
Cefadroxil—Haemorrhage—Bleomycin—melanoma	0.000659	0.0075	CcSEcCtD
Cefadroxil—Neutropenia—Temozolomide—melanoma	0.000649	0.00739	CcSEcCtD
Cefadroxil—Agranulocytosis—Dactinomycin—melanoma	0.000638	0.00727	CcSEcCtD
Cefadroxil—Cefdinir—SLC15A2—melanoma	0.000621	0.0928	CrCbGaD
Cefadroxil—Cefaclor—SLC15A2—melanoma	0.000616	0.092	CrCbGaD
Cefadroxil—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000614	0.00699	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000613	0.00699	CcSEcCtD
Cefadroxil—Body temperature increased—Vemurafenib—melanoma	0.00061	0.00696	CcSEcCtD
Cefadroxil—Swelling—Docetaxel—melanoma	0.000605	0.0069	CcSEcCtD
Cefadroxil—Hepatic failure—Docetaxel—melanoma	0.000594	0.00677	CcSEcCtD
Cefadroxil—Cefradine—SLC15A2—melanoma	0.00059	0.0882	CrCbGaD
Cefadroxil—Amoxicillin—SLC15A2—melanoma	0.00059	0.0882	CrCbGaD
Cefadroxil—Erythema multiforme—Dactinomycin—melanoma	0.000581	0.00662	CcSEcCtD
Cefadroxil—Haemoglobin—Carmustine—melanoma	0.000578	0.00658	CcSEcCtD
Cefadroxil—Haemorrhage—Carmustine—melanoma	0.000575	0.00655	CcSEcCtD
Cefadroxil—Hypersensitivity—Vemurafenib—melanoma	0.000569	0.00648	CcSEcCtD
Cefadroxil—Haemoglobin—Temozolomide—melanoma	0.000558	0.00636	CcSEcCtD
Cefadroxil—Haemorrhage—Temozolomide—melanoma	0.000556	0.00633	CcSEcCtD
Cefadroxil—Asthenia—Vemurafenib—melanoma	0.000554	0.00631	CcSEcCtD
Cefadroxil—Pruritus—Vemurafenib—melanoma	0.000546	0.00622	CcSEcCtD
Cefadroxil—Diarrhoea—Vemurafenib—melanoma	0.000528	0.00602	CcSEcCtD
Cefadroxil—Erythema multiforme—Temozolomide—melanoma	0.000525	0.00598	CcSEcCtD
Cefadroxil—Ampicillin—SLC15A2—melanoma	0.000523	0.0782	CrCbGaD
Cefadroxil—Dizziness—Vemurafenib—melanoma	0.000511	0.00582	CcSEcCtD
Cefadroxil—Vomiting—Vemurafenib—melanoma	0.000491	0.00559	CcSEcCtD
Cefadroxil—Rash—Vemurafenib—melanoma	0.000487	0.00555	CcSEcCtD
Cefadroxil—Cefotaxime—SLC15A2—melanoma	0.000487	0.0727	CrCbGaD
Cefadroxil—Dermatitis—Vemurafenib—melanoma	0.000486	0.00554	CcSEcCtD
Cefadroxil—Headache—Vemurafenib—melanoma	0.000484	0.00551	CcSEcCtD
Cefadroxil—Cramp muscle—Docetaxel—melanoma	0.000481	0.00548	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000481	0.00548	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000481	0.00548	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Docetaxel—melanoma	0.000471	0.00537	CcSEcCtD
Cefadroxil—Anaphylactic shock—Bleomycin—melanoma	0.000468	0.00533	CcSEcCtD
Cefadroxil—Nausea—Vemurafenib—melanoma	0.000459	0.00523	CcSEcCtD
Cefadroxil—Thrombocytopenia—Bleomycin—melanoma	0.000458	0.00522	CcSEcCtD
Cefadroxil—Angioedema—Temozolomide—melanoma	0.000442	0.00503	CcSEcCtD
Cefadroxil—Pancytopenia—Docetaxel—melanoma	0.000438	0.00499	CcSEcCtD
Cefadroxil—Vertigo—Temozolomide—melanoma	0.000434	0.00495	CcSEcCtD
Cefadroxil—Convulsion—Carmustine—melanoma	0.000434	0.00494	CcSEcCtD
Cefadroxil—Neutropenia—Docetaxel—melanoma	0.000432	0.00492	CcSEcCtD
Cefadroxil—Thrombocytopenia—Dactinomycin—melanoma	0.000427	0.00487	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Bleomycin—melanoma	0.000426	0.00486	CcSEcCtD
Cefadroxil—Cefalotin—SLC15A2—melanoma	0.00042	0.0628	CrCbGaD
Cefadroxil—Convulsion—Temozolomide—melanoma	0.000419	0.00477	CcSEcCtD
Cefadroxil—Arthralgia—Temozolomide—melanoma	0.000412	0.00469	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000408	0.00465	CcSEcCtD
Cefadroxil—Thrombocytopenia—Carmustine—melanoma	0.0004	0.00456	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000398	0.00453	CcSEcCtD
Cefadroxil—Anaphylactic shock—Temozolomide—melanoma	0.000395	0.0045	CcSEcCtD
Cefadroxil—Thrombocytopenia—Temozolomide—melanoma	0.000386	0.0044	CcSEcCtD
Cefadroxil—Agranulocytosis—Docetaxel—melanoma	0.000384	0.00438	CcSEcCtD
Cefadroxil—Cephalexin—SLC15A2—melanoma	0.000382	0.0571	CrCbGaD
Cefadroxil—Musculoskeletal discomfort—Carmustine—melanoma	0.000372	0.00424	CcSEcCtD
Cefadroxil—Urticaria—Bleomycin—melanoma	0.000372	0.00423	CcSEcCtD
Cefadroxil—Haemoglobin—Docetaxel—melanoma	0.000371	0.00423	CcSEcCtD
Cefadroxil—Body temperature increased—Bleomycin—melanoma	0.00037	0.00421	CcSEcCtD
Cefadroxil—Haemorrhage—Docetaxel—melanoma	0.000369	0.00421	CcSEcCtD
Cefadroxil—Somnolence—Carmustine—melanoma	0.000363	0.00414	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Temozolomide—melanoma	0.00036	0.0041	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Dactinomycin—melanoma	0.000357	0.00407	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Carmustine—melanoma	0.000353	0.00402	CcSEcCtD
Cefadroxil—Somnolence—Temozolomide—melanoma	0.000351	0.004	CcSEcCtD
Cefadroxil—Erythema multiforme—Docetaxel—melanoma	0.000349	0.00398	CcSEcCtD
Cefadroxil—Dyspepsia—Temozolomide—melanoma	0.000347	0.00396	CcSEcCtD
Cefadroxil—Abdominal pain—Dactinomycin—melanoma	0.000345	0.00393	CcSEcCtD
Cefadroxil—Body temperature increased—Dactinomycin—melanoma	0.000345	0.00393	CcSEcCtD
Cefadroxil—Hypersensitivity—Bleomycin—melanoma	0.000345	0.00393	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Temozolomide—melanoma	0.000341	0.00388	CcSEcCtD
Cefadroxil—Asthenia—Bleomycin—melanoma	0.000336	0.00382	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Carmustine—melanoma	0.000334	0.0038	CcSEcCtD
Cefadroxil—Pruritus—Bleomycin—melanoma	0.000331	0.00377	CcSEcCtD
Cefadroxil—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.000324	0.323	CbGpPWpGaD
Cefadroxil—Abdominal pain—Carmustine—melanoma	0.000323	0.00368	CcSEcCtD
Cefadroxil—Body temperature increased—Carmustine—melanoma	0.000323	0.00368	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Temozolomide—melanoma	0.000323	0.00368	CcSEcCtD
Cefadroxil—Hypersensitivity—Dactinomycin—melanoma	0.000321	0.00366	CcSEcCtD
Cefadroxil—Urticaria—Temozolomide—melanoma	0.000314	0.00357	CcSEcCtD
Cefadroxil—Asthenia—Dactinomycin—melanoma	0.000313	0.00357	CcSEcCtD
Cefadroxil—Abdominal pain—Temozolomide—melanoma	0.000312	0.00355	CcSEcCtD
Cefadroxil—Body temperature increased—Temozolomide—melanoma	0.000312	0.00355	CcSEcCtD
Cefadroxil—Muscle spasms—Docetaxel—melanoma	0.000309	0.00352	CcSEcCtD
Cefadroxil—Hypersensitivity—Carmustine—melanoma	0.000301	0.00343	CcSEcCtD
Cefadroxil—Diarrhoea—Dactinomycin—melanoma	0.000299	0.0034	CcSEcCtD
Cefadroxil—Vomiting—Bleomycin—melanoma	0.000297	0.00339	CcSEcCtD
Cefadroxil—Rash—Bleomycin—melanoma	0.000295	0.00336	CcSEcCtD
Cefadroxil—Dermatitis—Bleomycin—melanoma	0.000295	0.00336	CcSEcCtD
Cefadroxil—Asthenia—Carmustine—melanoma	0.000293	0.00334	CcSEcCtD
Cefadroxil—Hypersensitivity—Temozolomide—melanoma	0.000291	0.00331	CcSEcCtD
Cefadroxil—Asthenia—Temozolomide—melanoma	0.000283	0.00323	CcSEcCtD
Cefadroxil—Diarrhoea—Carmustine—melanoma	0.000279	0.00318	CcSEcCtD
Cefadroxil—Pruritus—Temozolomide—melanoma	0.000279	0.00318	CcSEcCtD
Cefadroxil—Convulsion—Docetaxel—melanoma	0.000279	0.00317	CcSEcCtD
Cefadroxil—Nausea—Bleomycin—melanoma	0.000278	0.00317	CcSEcCtD
Cefadroxil—Vomiting—Dactinomycin—melanoma	0.000277	0.00316	CcSEcCtD
Cefadroxil—Rash—Dactinomycin—melanoma	0.000275	0.00313	CcSEcCtD
Cefadroxil—Arthralgia—Docetaxel—melanoma	0.000274	0.00312	CcSEcCtD
Cefadroxil—Dizziness—Carmustine—melanoma	0.00027	0.00308	CcSEcCtD
Cefadroxil—Diarrhoea—Temozolomide—melanoma	0.00027	0.00308	CcSEcCtD
Cefadroxil—Anaphylactic shock—Docetaxel—melanoma	0.000262	0.00299	CcSEcCtD
Cefadroxil—Dizziness—Temozolomide—melanoma	0.000261	0.00297	CcSEcCtD
Cefadroxil—Vomiting—Carmustine—melanoma	0.00026	0.00296	CcSEcCtD
Cefadroxil—Nausea—Dactinomycin—melanoma	0.000259	0.00295	CcSEcCtD
Cefadroxil—Cefpiramide—ALB—melanoma	0.000258	0.0386	CrCbGaD
Cefadroxil—Rash—Carmustine—melanoma	0.000258	0.00293	CcSEcCtD
Cefadroxil—Dermatitis—Carmustine—melanoma	0.000257	0.00293	CcSEcCtD
Cefadroxil—Thrombocytopenia—Docetaxel—melanoma	0.000257	0.00293	CcSEcCtD
Cefadroxil—Headache—Carmustine—melanoma	0.000256	0.00292	CcSEcCtD
Cefadroxil—Vomiting—Temozolomide—melanoma	0.000251	0.00286	CcSEcCtD
Cefadroxil—Rash—Temozolomide—melanoma	0.000249	0.00284	CcSEcCtD
Cefadroxil—Dermatitis—Temozolomide—melanoma	0.000249	0.00283	CcSEcCtD
Cefadroxil—Headache—Temozolomide—melanoma	0.000247	0.00282	CcSEcCtD
Cefadroxil—Nausea—Carmustine—melanoma	0.000243	0.00276	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000239	0.00272	CcSEcCtD
Cefadroxil—Nausea—Temozolomide—melanoma	0.000234	0.00267	CcSEcCtD
Cefadroxil—Somnolence—Docetaxel—melanoma	0.000233	0.00266	CcSEcCtD
Cefadroxil—Dyspepsia—Docetaxel—melanoma	0.000231	0.00263	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Docetaxel—melanoma	0.000227	0.00258	CcSEcCtD
Cefadroxil—Cefonicid—ALB—melanoma	0.000225	0.0336	CrCbGaD
Cefadroxil—Gastrointestinal pain—Docetaxel—melanoma	0.000215	0.00245	CcSEcCtD
Cefadroxil—Abdominal pain—Docetaxel—melanoma	0.000207	0.00236	CcSEcCtD
Cefadroxil—Body temperature increased—Docetaxel—melanoma	0.000207	0.00236	CcSEcCtD
Cefadroxil—Hypersensitivity—Docetaxel—melanoma	0.000193	0.0022	CcSEcCtD
Cefadroxil—Asthenia—Docetaxel—melanoma	0.000188	0.00215	CcSEcCtD
Cefadroxil—Pruritus—Docetaxel—melanoma	0.000186	0.00212	CcSEcCtD
Cefadroxil—Diarrhoea—Docetaxel—melanoma	0.00018	0.00205	CcSEcCtD
Cefadroxil—Dizziness—Docetaxel—melanoma	0.000174	0.00198	CcSEcCtD
Cefadroxil—Vomiting—Docetaxel—melanoma	0.000167	0.0019	CcSEcCtD
Cefadroxil—Rash—Docetaxel—melanoma	0.000165	0.00189	CcSEcCtD
Cefadroxil—Dermatitis—Docetaxel—melanoma	0.000165	0.00188	CcSEcCtD
Cefadroxil—Headache—Docetaxel—melanoma	0.000164	0.00187	CcSEcCtD
Cefadroxil—Nausea—Docetaxel—melanoma	0.000156	0.00178	CcSEcCtD
Cefadroxil—Cefoperazone—ALB—melanoma	0.000132	0.0198	CrCbGaD
Cefadroxil—Ampicillin—ALB—melanoma	0.000113	0.0168	CrCbGaD
Cefadroxil—Cefazolin—ALB—melanoma	0.000109	0.0163	CrCbGaD
Cefadroxil—Cefalotin—ALB—melanoma	9.04e-05	0.0135	CrCbGaD
Cefadroxil—Cephalexin—ALB—melanoma	8.22e-05	0.0123	CrCbGaD
Cefadroxil—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	4.52e-05	0.0451	CbGpPWpGaD
Cefadroxil—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	4.36e-05	0.0435	CbGpPWpGaD
Cefadroxil—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	4.2e-05	0.0419	CbGpPWpGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	2.66e-05	0.0266	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	2.57e-05	0.0256	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	2.47e-05	0.0246	CbGpPWpGaD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	2.17e-05	0.0216	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	1.96e-05	0.0196	CbGpPWpGaD
Cefadroxil—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	1.88e-05	0.0187	CbGpPWpGaD
Cefadroxil—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	1.74e-05	0.0174	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	1.64e-05	0.0163	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	1.2e-05	0.0119	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	1.19e-05	0.0119	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	1.15e-05	0.0114	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—melanoma	1.13e-05	0.0113	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	1.11e-05	0.0111	CbGpPWpGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	1.11e-05	0.011	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	1.1e-05	0.011	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCB5—melanoma	1.09e-05	0.0109	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC17A5—melanoma	1.09e-05	0.0108	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	1.08e-05	0.0108	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	1.03e-05	0.0102	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—melanoma	1.02e-05	0.0102	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	1e-05	0.01	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCB5—melanoma	9.87e-06	0.00984	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC6A11—melanoma	9.86e-06	0.00984	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC17A5—melanoma	9.82e-06	0.0098	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC6A11—melanoma	8.92e-06	0.00889	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—melanoma	8.51e-06	0.00849	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	8.29e-06	0.00827	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCB5—melanoma	8.24e-06	0.00822	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC17A5—melanoma	8.2e-06	0.00818	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	7.69e-06	0.00767	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ARL2—melanoma	7.56e-06	0.00754	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC6A11—melanoma	7.44e-06	0.00742	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ARL2—melanoma	6.84e-06	0.00682	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	6.05e-06	0.00603	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	5.83e-06	0.00581	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC15A2—melanoma	5.73e-06	0.00572	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ARL2—melanoma	5.71e-06	0.00569	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	5.61e-06	0.0056	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC17A5—melanoma	5.52e-06	0.0055	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	5.49e-06	0.00548	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC15A2—melanoma	5.18e-06	0.00517	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	5.09e-06	0.00508	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC6A11—melanoma	5.01e-06	0.005	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC17A5—melanoma	4.99e-06	0.00498	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	4.94e-06	0.00493	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	4.58e-06	0.00457	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC6A11—melanoma	4.53e-06	0.00452	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—melanoma	4.51e-06	0.0045	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC15A2—melanoma	4.33e-06	0.00432	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC17A5—melanoma	4.16e-06	0.00415	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—melanoma	4.08e-06	0.00407	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC6A11—melanoma	3.78e-06	0.00377	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.4e-06	0.00339	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	2.51e-06	0.0025	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	2.36e-06	0.00235	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.33e-06	0.00232	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC5A5—melanoma	2.29e-06	0.00229	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	2.19e-06	0.00218	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	2.15e-06	0.00215	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC5A5—melanoma	2.07e-06	0.00207	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—ALB—melanoma	1.95e-06	0.00194	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	1.91e-06	0.00191	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	1.78e-06	0.00177	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	1.75e-06	0.00174	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	1.73e-06	0.00173	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	1.62e-06	0.00162	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	1.58e-06	0.00158	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	1.32e-06	0.00132	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	1.2e-06	0.00119	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	1.11e-06	0.00111	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	1.09e-06	0.00109	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	9.88e-07	0.000986	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	8.25e-07	0.000823	CbGpPWpGaD
